Efficacy and Safety of NBI-98854 in Subjects With Tardive Dyskinesia
Clinical trial NCT01267188 · COMPLETED
Trial details
- NCT number
- NCT01267188
- Sponsor
- Neurocrine Biosciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2011-03-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.